These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 14597904

  • 1. [An increasing cholestasis].
    Wendum D, Corpechot C, Fléjou JF.
    Ann Pathol; 2003 Sep; 23(4):366-7. PubMed ID: 14597904
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prolonged cholestasis with ductopenia after administration of amoxicillin/clavulanic acid.
    Richardet JP, Mallat A, Zafrani ES, Blazquez M, Bognel JC, Campillo B.
    Dig Dis Sci; 1999 Oct; 44(10):1997-2000. PubMed ID: 10548348
    [No Abstract] [Full Text] [Related]

  • 10. Recurrent cholestasis by amoxicillin-clavulanic acid: the importance of a correct diagnosis of hepatotoxicity.
    Sánchez-Ruiz-Granados E, Bejarano-García A, Uceda-Torres E.
    Rev Esp Enferm Dig; 2012 Dec; 104(11):616-7. PubMed ID: 23368660
    [No Abstract] [Full Text] [Related]

  • 11. [Amoxicillin-clavulanic acid hepatotoxicity].
    Ballester Fayos J, Rodríguez Gil FJ, Paredes Arquiola JM, García del Castillo G, Antón-Conejero MD, Añón Rodríguez R, Moreno-Osset E.
    Gastroenterol Hepatol; 1998 Feb; 21(2):114-5. PubMed ID: 9580395
    [No Abstract] [Full Text] [Related]

  • 12. Severe toxic hepatitis associated with amoxycillin and clavulanic acid.
    Ersoz G, Karasu Z, Yildiz C, Akarca US, Yuce G, Batur Y.
    J Clin Pharm Ther; 2001 Jun; 26(3):225-9. PubMed ID: 11422607
    [Abstract] [Full Text] [Related]

  • 13. [Cholestatic hepatitis from amoxicillin-clavulanic acid].
    Cabelleria Rovira E, Masso Ubeda RM, Arago López JV, Sanchís Closa A.
    An Med Interna; 1992 Jul; 9(7):360-1. PubMed ID: 1633249
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatitis and augmentin.
    Reddy KR, Schiff ER.
    Dig Dis Sci; 1990 Aug; 35(8):1045-6. PubMed ID: 2384035
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Acute hepatocellular lesion induced by amoxicillin-clavulanic acid].
    Julve R, García A, Gómez A, Primo J, Molés JR, Hinojosa J.
    Gastroenterol Hepatol; 1998 Feb; 21(2):92-4. PubMed ID: 9549187
    [Abstract] [Full Text] [Related]

  • 19. Cholestatic hepatitis after therapy with amoxicillin/clavulanate potassium.
    Schneider JE, Kleinman MS, Kupiec JW.
    N Y State J Med; 1989 Jun; 89(6):355-6. PubMed ID: 2739957
    [No Abstract] [Full Text] [Related]

  • 20. History of drug-induced hepatitis and risk of amoxicillin/clavulanate-induced hepatotoxicity.
    Schey R, Avni Y, Bruck R, Shirin H.
    Ann Pharmacother; 2001 Sep; 35(9):1142-3. PubMed ID: 11573870
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.